ArticleDrug design, development and therapy2026
Formulation and Physicochemical Characterization of Capecitabine-Loaded Cubosomes for Enhanced Drug Delivery System.
Article in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Capecitabine (CPB) is a hydrophilic anticancer drug classified as Biopharmaceutics Classification System (BCS) Class III, which presents challenges for effective dermal delivery. Objectives: This study aimed to develop and characterize a topical cubosomal formulation encapsulating CPB to enhance its delivery efficiency. Significance: By evaluating in vitro release and permeation behavior, this work investigates the potential of CPB-loaded cubosomes as an innovative targeted drug delivery system capable of achieving higher localized drug concentrations. Methods: CPB-loaded cubosomes were formulated using Pluronic F-68, Tween 80, and glyceryl monooleate. Four formulations were prepared by varying the concentrations of these excipients. A molten mixture of Pluronic F-68 and glyceryl monooleate was prepared, followed by incorporation of CPB under continuous stirring. The developed cubosomes were characterized for particle size, pH, zeta potential, viscosity, morphology (SEM), and in vitro drug release and permeation profiles. Results: The optimized formulation exhibited a particle size of 177.66 nm, and SEM confirmed well-segregated, nanosized cubic structures. Drug release from the formulations ranged from 40% to 67%, while permeation efficiency varied from 50% to 92%, demonstrating enhanced dermal transport of CPB. Conclusion: The CPB-loaded cubosomes demonstrated favorable physicochemical characteristics and significantly improved drug release and permeation, suggesting strong potential as an effective topical delivery system for capecitabine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.